This is the template sandbox page for Template:Infobox drug/licence (diff). |
This template is used on approximately 9,900 pages and changes may be widely noticed. Test changes in the template's /sandbox or /testcases subpages, or in your own user subpage. Consider discussing changes on the talk page before implementing them. |
- Note: whether the infobox shows "LicenSe" or "LicenCe" is set by
|engvar=
. Default is en-US ("LicenSe"), alternative is|engvar=en-UK
. It should follow the article style, per WP:ENGVAR. - Testcases are at /testcases3
Usage
edit| licence_CA =
| licence_EU =
| INN_EMA =
| DailyMedID =
| licence_US =
Clinical data | |
---|---|
License data |
{{Infobox drug
| drug_name = demo
| INN = Sildenafil
| licence_CA = Viagra
| licence_EU = yes
| INN_EMA = Sildenafil
| DailyMedID =
| licence_US = Viagra
}}
Clinical data | |
---|---|
License data |
{{Infobox drug
| drug_name = demo
| INN = Sildenafil
| licence_EU = Viagra
| DailyMedID =
| licence_US = Viagra
}}
Clinical data | |
---|---|
License data |
{{Infobox drug
| drug_name = demo
| INN = Sildenafil
| licence_EU = Viagra
| DailyMedID = Viagra
}}
Clinical data | |
---|---|
License data |
{{Infobox drug
| drug_name = demo
| INN = Sildenafil
| licence_CA = Viagra
| licence_EU = Viagra
| DailyMedID = Viagra
| license_US = Viagra
}}
licence_EU (EMA)
editDrugs that have an EU licence (provided by EMA) should have a link to the EMA site. EMA licences are by INN. The list if EMA licences (INNs) per June 2017 is here (623 INNs).
he link is added by setting |licence_EU=yes
. The infobox will then show an external link to the EMA licence page (EPAR publications).
In some cases, the INN used by EMA is different from the article's INN. In those cases, use |INN_EMA=
to give the name that should be linked to on the EMA site.
As said, EMA licences are given for an INN. When |licence_EU=yes
is set, the infobox uses as INN (in this order of priority): |INN_EMA=
, |INN=
, |drug_name=
, <PAGENAME>.
Drugs with the EMA-link are listed in Category:Drug has EMA link (204)